Helix pomatia agglutinin (HPA) is a lectin that has been used extensively in histopathology, since its binding to tissue sections from breast and colon cancers is correlated with the worst prognosis for the patients. The lectin recognizes α-D-N-acetylgalactosamine (αGalNAc) containing epitopes which are only present in cancer cell lines having a high likelihood to undergo metastasis, such as the HT29 cancer colon cell line. Several breast cancer cell lines have also been shown to be labeled, although IGROV1, an ovarian cancer cell line, is not. Inhibition studies, using GalNAc monosaccharides, are reported here, showing that the labeling is dependent upon the presence of carbohydrate epitopes. The crystal structures of the lectin complexed with two GalNAc containing epitopes associated with cancer, the Tn (αGalNAc-Ser) and Forssman (αGalNAc1-3GalNAc) antigens, show the lectin's specificity for GalNAc is due to a particular network of hydrogen bonds. A histidine residue makes hydrophobic contact with the aglycon, rationalizing the preference for GalNAc bearing an additional sugar or amino acid in the α position. These structures provide the molecular basis for the use of HPA in metastasis research.
Introduction
Glycoproteins and glycolipids present on the surface of cancer cells are markedly different from those of normal cells (Hakomori 1984; Feizi 1985) . Some of these changes in cell surface properties have been directly correlated with tumor progression and metastatic potential (Dennis et al. 1999 ). The expression of N-acetylgalactosamine (GalNAc) on the surface of cancer cells is one of the signatures of the altered glycosylation pathway, and has been the subject of many investigations (Brooks 2000) . Amongst GalNAc-containing cancer epitopes, the Tn determinant (αGalNAcO-Ser/Thr) is one of the most specific human tumor associated structures. Present in mucin-type O-glycans, this antigen is shielded in both healthy and benign-diseased tissues, but uncovered in approximately 90% of carcinomas (Springer 1997) . The Forssman antigen (αGalNAc1-3αGalNAc-R) is another cancer epitope of interest. Present on glycolipids, it is a normal constituent of fetal tissues and virtually absent in healthy adults, but it has been detected in elevated levels in various human lung, breast, and gastric cancer cell lines (Hakomori 1984) .
With their fine specificity for oligosaccharides, lectins isolated from some legume plants have proven to be useful markers in cancer histochemistry. For example, Vicia villosa and Dolichos biflorus beans have been used as sources of αGalNAc-binding lectins. Two decades ago, the binding of an agglutinin from the roman snail (Helix pomatia -HPA), was demonstrated to have a predictive value for breast cancer recurrence and survival (Leathem and Brooks 1987) . These results initiated the strong interest in HPA as a potential marker for cancer research (Brooks and Wilkinson 2003) . When applied to tissue sections from primary breast and colon cancers, HPA was shown to bind to tumors from patients with a very poor prognosis (Brooks 2000; Mitchell and Schumacher 1999) . Moreover, when various human and colon cancer cell lines were transplanted into severe combined immuno deficient (SCID) mice, only the HPA positive cell lines metastasized, whereas the HPA-negative ones did not (Schumacher and Adam 1997) . When compared to legume lectin binding to lung adenocarcinomas, only HPA was demonstrated to have a significant independent prognostic factor for survival (Laack et al. 2002) . The αGalNAc-containing glycoconjugates that are associated with metastasis and which bind to HPA have not yet been identified. Both the Tn antigen present on mucins and the Forssman antigen present on glycolipids are good candidates. However, the results of recent studies are in favor of a more complex epitope, named HPAgly-1, that has been found associated with 11 glycoproteins overexpressed in breast cancer (Dwek et al. 2001) .
Early biochemical studies on HPA demonstrated that the protein assembles as a hexamer with a total molecular weight of 79 kDa (Hammarström and Kabat 1969) . The binding preference was established to be (strongest preference first): Forssman antigen (αGalNAc1-3GalNAc-R) > Blood group A substance (αGalNAc1-3[αFuc1-2]Gal) > Tn antigen (αGalNAc-Ser/Thr) > GalNAc > GlcNAc; therefore confirming the specificity for a terminal α-N-acetyl-D-galactosamine (αGalNAc) residue (Wu and Sugii 1991) . The recent determination of the crystal structure of HPA confirmed the hexameric state of the lectin, each monomer consisting of a six-stranded antiparallel β-sandwich (Sanchez et al. 2006 ). This unique oligomeric arrangement results in groups of three GalNAc binding sites, with each group J Lescar et al. located at opposite ends of the hexamer. The GalNAc specificity is created by a network of hydrogen bonds that involves two neighboring monomers.
We report here the crystal structures of HPA complexed with two ligands that are described as tumor markers: the Tn (αGalNAc-Ser) and Forssman (αGalNAc1-3GalNAc) antigens. Although the oligosaccharide epitope is not yet characterized the HPA binding to HT29 cells, a highly metastatic colon cancer cell line, has been shown to be inhibited by GalNAc. The description of the complexes allows the fine specificity of the lectin for GalNAc-containing epitopes to be rationalized.
Results and discussion

Labeling of colon cancer cells with biotinylated HPA
The purity and binding properties of commercial HPA extracted from snails may present lot-to-lot variations. The absence of protein contaminant was previously verified by gel electrophoresis and mass spectrometry, but this previous study has shown the (Sanchez et al. 2006 ). Prior to structural study, we ensured that the commercial source of HPA used for crystallization trials binds to cancer cells in a GalNAc-dependent manner. The HT29 cells were chosen since they are classically considered as a positive control for HPA binding (Schumacher and Adam 1997) .
The labeling and inhibition conditions were adapted from those described previously for fixed tissues (Brooks and Leathem 1998) . Figure 1A and B displays the results obtained using a solution of biotinylated HPA at 20 µg/mL. More than 90% of the HT29 cells are labeled. This result is concentration dependent, since 70% of the cells are labeled for a HPA concentration of 10 µg/mL and only 40% for a concentration of 5 µg/mL (data not shown). Furthermore, the labeling is fully inhibited when GalNAc (100 µM) is added to the HPA solution ( Figure 1C ).
The labeling of other cancer cell lines has also been performed with the use of Cy5-labeled HPA. As previously reported (Schumacher and Adam 1997) , the strongest labeling is observed for the colon and breast cell lines that are reported to have the higher metastasis potential (Table I ). Figure 1D shows the strong positive labeling of HT29 or weak homogenous labeling with the human non small cell lung carcinoma H1299 ( Figure 1E ), whereas the ovarian cancer cell line IGROV1 is not labeled ( Figure 1F ). The control experiment with GalNAc (100 µM) added to the HPA solution is shown in Figure 1G and no labeling is observed. Similarly, no color is observed when cells are incubated in Cy5 not attached to HPA. In several cases, such as the human non small cell lung cancer cell line A539 (data not shown), the cells are not labeled, except for a small percentage that display strong staining (1-10%). This behavior has been reported before (Brooks et al. 2001 ) and may correspond either to the "fugitive" expression of particular glycoconjugates on the surface of cultured cancer cell during their cycles, or to the apparition of metastatic character in a subpopulation of cells.
Crystal structure of HPA/cancer epitope complexes HPA co-crystallized with both ligands yielded crystals of space group P6 3 22 and diffracting to 2.8Å resolution (Table II) . The structures were determined using the molecular replacement method with the crystal structure of HPA/GalNAc complex (PDB code 2CCV) as the search probe. The structure complexed with GalNAc residue, together with the peptide and nucleotide sequences, has been described previously (Sanchez et al. 2006 ). In both complexes, HPA adopts an immunoglobulin like fold formed by six β-strands and one long loop protruding from the barrel (Figure 2 ). An N-linked glycan is found attached to Asn34 of each monomer, but the quality of the electron density permitted the modeling only of the first GlcNAc residue. The overall quaternary state is hexameric with the trimers associated back-to-back through disulfide bridges formed from the faceto-face Cys42 residues ( Figure 2B ). The resulting geometry consists of two negatively charged and almost flat faces that are almost 100Å apart ( Figure 2C ). Each face carries three ligand binding sites, created between the monomers (Figure 2A ), on the points of an equilateral triangle with sides of 25Å and in an ideal topology for the multivalent binding of carbohydrate epitopes on cancer cell surfaces.
Structure of HPA complexed with cancer epitopes
The Tn carbohydrate binding site consists of a shallow pocket, but involves a strong network of hydrogen bonds between the monosaccharide and the protein ( Figure 3A and Table III ). The lectin preference for the galacto configuration, i.e., axial orientation of the O4 oxygen, is determined by three hydrogen bonds formed between this hydroxyl group and the side chains of neighboring amino acids. The higher affinity for N-acetyl containing monosaccharides is due to a hydrogen bond between the carbonyl of this group and an amine nitrogen of the protein backbone. Other hydrogen bonds involve the hydroxyl groups O3 and O6, and the ring oxygen O5. Van der Waals contacts are limited to the CH 2 group of C6 that interacts with Tyr89 of the neighboring monomer. The serine residue of the Tn antigen does not establish hydrogen bonds with the protein. However, a strong hydrophobic interaction is created between the Cα of the Tn serine with the side chain of His84. The serine extends out from the binding site in the flat surface of the trimer, thereby sterically allowing a longer ligand, e.g., a αGalNAc-containing mucin, to be bound by the snail lectin ( Figure 3B ). Similarly, in the HPA/Forssman complex, the disaccharide extends its reducing extremity out of the trimer surface in a conformation that is compatible with longer ligand binding ( Figure 3C and 3D) . The conformation of the disaccharide ( (O5 C1 O1 C3 ) = 81
• , (C1 O1 C3 C4 ) = 100 • ) is slightly different to the predicted lower energy minimum ( = 80
• , = 80
• ) (Imberty et al. 1994 ) but belongs to the same conformational family, as does the Forssman disaccharide previously observed interacting with the legume lectin from D. biflorus ( = 88
• , = 70 • ) (Hamelryck et al. 1999 ). In the HPA/Forssman complex, the nonreducing GalNAc establishes the same hydrogen bond network as in the HPA/Tn complex. Only the conformation of the exocyclic group at C5 displays some variations. The second GalNAc residue does not form any hydrogen bonds to the protein. Nevertheless, the hydrophobic face of this residue, i.e., the CH moieties at C4 and C5, makes van der Waals contacts with His84, thus giving His84 an important role in configuring the HPA binding properties; it prevents the binding of compounds with equatorial substituents at C1. This, therefore, provides the binding preference for GalNAc residues with an alpha configuration and also favors hydrophobic interactions with aglycon substituents, rationalizing the higher affinity reported for the Forssman and Tn antigens, when compared to GalNAc monosaccharides (Wu and Sugii 1991) .
The ability of HPA to agglutinate red cells from individuals with blood group A phenotype (Hammarström and Kabat 1971) can also be rationalized from the crystal structure of the HPA/Forssman antigen complex. The binding of blood group A epitope (αGalNAc1-3[αFuc1-2]Gal) can occur with the currently observed orientation of GalNAc in the binding site. A fucose residue branched on position 2 of the reducing galactose will be at the same location as the N-acetyl group in reducing GalNAc for the Forssman disaccharide and the binding properties will not be affected. 
Conclusions
The current absence of progress in breast and colon cancer treatment is due to our lack of knowledge of the underlying mechanisms of metastasis that lead to secondary tumor deposits. HPA is widely used in metastasis research, because of its specificity for cancer cells in the very early stages of the metastatic process, although the molecular basis of the interaction with cancer epitopes is not yet well understood. The structures presented here thus provide for the first time an explanation of the high specificity of this lectin for two cancer associated antigens, and should guide the development of new engineered markers that could be used in cancer research and as diagnostic tools.
Materials
Free and biotinylated H. pomatia agglutinin (HPA) were purchased from Sigma and Vector (Burlingame, CA). Monosaccharide and antigens were purchased from Sigma and Dextra Laboratories (Reading, UK)
Labeling of cancer cells
The colon cancer HT29 cell line was obtained from Dr Corinne Albiges-Rizo (INSERM U823). The cells were maintained in DMEM medium (Invitrogen Carlsbad, CA) supplemented with 10% heat-inactivated fetal calf serum, 4.5 g/L glucose, 100 units/mL penicillin (Invitrogen), and 100 µg/mL streptomycin (Invitrogen) and kept at 37
• C in a 5% CO 2 humidified atmosphere. Cells were plated at mid-confluency on cover slips in 12-well plates and fixed in 2% paraformaldehyde in phosphate buffered saline (PBS), pH 7.4, for 5 min at room temperature. After two washes, endogeneous peroxydases were quenched by incubating cells in 3% v/v hydrogen peroxide in water for 20 min. Non specific interactions were minimized by saturating wells in PBS containing 5% (w/v) bovine serum albumin, during 30 min. The cells were then incubated with different concentrations of biotinylated HPA solution (500 µL), for 30 min. After the lectin binding step, the cells were incubated with horseradish peroxidase-labeled streptavidin (Sigma) diluted at 1:1000, for 30 min, and subsequently incubated with diaminobenzidine-HCl (0.7 mg/mL) and hydrogen peroxide (3% v/v). Cells were counterstained using fast nuclear red and cover slips were mounted with Moeviol and examined on a BX41 Olympus microscope. Unless otherwise specified, all solutions were made in PBS containing 3% (w/v) serum albumin bovine and each step was followed by three washes in PBS.
Other cancer cell lines were obtained from the ATCC or were kindly provided by Dr L. Poulain (Centre François Baclesse, France). Labeling of HPA by Cy5 was performed using the Cy5 monofunctional dye ester-kit provided by Amersham. Cells were fixed as previously, rinsed in PBS, and incubated for 30 min at room temperature with 10 µg/mL cy5-labeled HPA. After rinsing, nuclei were stained with 5 µM Hoechst 33342, and the cover slips were inverted onto glass slides using Mowiol (Calbiochem, San Diego, CA) mounting medium. The slides were observed with a confocal laser scanning microscopy (CLSM) (LSM510, Zeiss, France).
Crystallization experiments
Crystallization trials were performed with Hampton crystallization screens I and II (Hampton Research, Laguna Niguel, CA).
After optimization, crystals were obtained using the hanging drop method with precipitation solution containing lithium sulfate (2.0 M) and ammonium sulfate (3.5 M) in sodium citrate buffer (1.5 M, pH 6.5). Drops were made of an equal volume of reservoir solution and protein solution at 10 mg/mL with ligand at 3-fold excess in molarity.
Crystals were cryocooled at 100 K, after soaking them for the shortest possible time in precipitant solution with 25% PEG 3000 and 25% glycerol added. Data images were recorded on an ADSC Q4R CCD detector (Quantum Corp, Il, USA) at beamline ID14-2 at the ESRF (Grenoble, France). Diffraction images were processed using MOSFLM (Leslie 1992 ) and intensities were scaled and truncated to structure factors using the CCP4 (1994) programs SCALA and TRUNCATE.
Structure determination
The structure of HPA/GalNAc complex (PDB code 2CCV) was used as the search model for molecular replacement for the Tn and Forssman complexes with the use of MOLREP (Vagin and Teplyakov 1997) . In each complex, the few missing amino acids and all sugar residues clearly defined in density were positioned manually using the O software (Jones et al. 1991) . Refinement cycles with Refmac (Murshudov et al. 1997) , including further automatic water molecule placement using ARP/wARP (Perrakis et al. 1999) , manual rebuilding with O resulted in final models with refinement statistics listed in Table II . Stereochemical checks were performed with the PROCHECK program (Laskowski et al. 1993 ). All graphical representations have been performed with the Sybyl program (Tripos Inc, Saint-Louis) and the MOLCAD software (Waldherr-Teschner et al. 1992 ).
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